Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Healthpeak Properties (DOC)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-05
$20.12-0.25%
Close 2026-11-05 · 1-day change
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.22 → 0.20 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for DOC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain strong balance sheet to support growth and dividends | The balance sheet is strong, supporting growth and dividend payments near 6%. | Intact | Significant deterioration in credit ratings or liquidity | Credit metrics stable; no deterioration reported May 2026 news highlights healthy balance sheet; Q1-Q3 2026 earnings beats support financial stability. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a real estate business with a growth platform in senior housing and outpatient medical assets. The multi-year view is intact and recently shifted from mixed to mildly favorable, though confidence is medium and execution remains important.
The valuation evidence is mixed: one measure indicates DOC is cheap versus peers, while another points to a substantial premium; the model confidence is low. Expectations appear only modestly supportive, and the priced-in tag is unjustified, with low flagged fragility.
Near-term results have been strong, including earnings beats in May and August, and guidance was raised as of August. Janus Living has posted strong growth, while same-store cash NOI growth has been uneven; capital recycling is producing substantial proceeds but remains a mixed priority. Near-term earnings risk is described as low, though the evidence notes an erratic surprise record and a high-miss-rate industry.
Over the next one to three years, the thesis depends on continued senior housing expansion and steadier same-store cash NOI growth. A guidance reversal after the recent increase would damage credibility, while Fed rate cuts could support the real estate sector. Weak results or guidance from sector peers could also remove a helpful sector backdrop.
The multi-year view remains intact, supported by recent execution and senior housing growth, but uneven property-level growth and mixed valuation signals leave meaningful uncertainty. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company reaffirms its 2026 FFO guidance at $1.68 to $1.72 per share. |
| Intact |
| EPS falls below $0.46 in FY26 |
Diluted EPS: $0.02 per share FY2026-Q3; GAAP. Published target: >= $0.46 per share. Annual target cannot be compared with a quarterly or TTM observation. Nov 3, 20260.02 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
FFO per share at or above $1.68 in 2026 | The company reaffirms its 2026 FFO guidance at $1.68 to $1.72 per share. | Intact | FFO per share falls below $1.68 in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth near 1.7% in 2026 | A supporting condition in Healthpeak Properties's published investment case. The stated target is >= 1.7% YoY. | Broken | Revenue growth falls below 1.7% in FY26 | Revenue growth: 16.29% FY2026-Q3; GAAP. Published target: >= 1.7% YoY. Annual target cannot be compared with a quarterly or TTM observation. Nov 3, 202616.294574 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.10 → $0.20 · observed estimates
$3.13B → $3.14B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.10 | $3,132,683,205 | 3 / 6 |
| 2026-07-25 | $-0.15 | $2,962,950,210 | 1 / 9 |
| 2026-07-26 | $0.10 | $3,125,727,132 | 3 / 6 |
| 2026-07-27 | $-0.15 | $2,962,950,210 | 1 / 9 |
| 2026-07-28 | $0.10 | $3,125,727,132 | 3 / 6 |
| 2026-07-29 | $0.10 | $3,125,724,405 | 3 / 6 |
| 2026-07-30 | $0.10 | $3,125,724,405 | 3 / 6 |
| 2026-07-31 | $0.10 | $3,125,724,405 | 3 / 6 |
| 2026-08-01 | $0.10 | $3,125,724,405 | 3 / 6 |
| 2026-08-02 | $-0.15 | $2,962,950,210 | 1 / 9 |
| 2026-08-03 | $0.10 | $3,125,724,405 | 3 / 6 |
| 2026-08-04 | $0.10 | $3,125,724,405 | 3 / 6 |
| 2026-08-05 | $-0.15 | $2,962,950,210 | 1 / 9 |
| 2026-08-06 | $0.10 | $3,125,724,405 | 3 / 6 |
| 2026-08-07 | $0.12 | $3,125,724,405 | 3 / 6 |
| 2026-08-08 | $-0.15 | $2,962,950,210 | 1 / 9 |
| 2026-08-09 | $-0.15 | $2,962,950,210 | 1 / 9 |
| 2026-08-10 | $0.12 | $3,125,724,405 | 3 / 6 |
| 2026-08-11 | $0.12 | $3,125,724,405 | 3 / 6 |
| 2026-08-12 | $-0.15 | $2,962,950,210 | 1 / 9 |
| 2026-08-13 | $0.12 | $3,125,724,405 | 3 / 6 |
| 2026-08-14 | $0.12 | $3,125,724,405 | 3 / 6 |
| 2026-08-15 | $0.12 | $3,125,724,405 | 3 / 7 |
| 2026-08-16 | $0.12 | $3,125,724,405 | 3 / 7 |
| 2026-08-17 | $0.12 | $3,125,724,405 | 3 / 7 |
| 2026-08-18 | $0.12 | $3,125,724,405 | 3 / 7 |
| 2026-08-19 | $0.12 | $3,125,724,405 | 3 / 6 |
| 2026-08-20 | $0.16 | $3,213,653,529 | 3 / 6 |
| 2026-08-21 | $0.16 | $3,213,653,529 | 4 / 7 |
| 2026-08-22 | $0.16 | $3,213,653,529 | 4 / 7 |
| 2026-08-23 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-08-24 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-08-25 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-08-26 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-08-27 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-08-28 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-08-29 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-08-30 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-08-31 | $0.17 | $3,232,281,444 | 4 / 7 |
| 2026-09-01 | $0.17 | $3,230,114,777 | 4 / 7 |
| 2026-09-02 | $0.17 | $3,214,853,977 | 4 / 7 |
| 2026-09-03 | $0.22 | $3,213,261,560 | 4 / 7 |
| 2026-09-04 | $0.22 | $3,216,576,195 | 4 / 7 |
| 2026-09-05 | $0.22 | $3,216,576,195 | 4 / 7 |
| 2026-09-06 | $0.22 | $3,216,576,195 | 4 / 7 |
| 2026-09-07 | $0.22 | $3,216,576,195 | 4 / 7 |
| 2026-09-08 | $0.22 | $3,216,576,195 | 4 / 7 |
| 2026-09-09 | $0.22 | $3,216,576,195 | 4 / 7 |
| 2026-09-10 | $0.22 | $3,216,576,195 | 4 / 7 |
| 2026-09-11 | $0.22 | $3,218,425,112 | 4 / 7 |
| 2026-09-12 | $0.22 | $3,218,425,112 | 4 / 7 |
| 2026-09-13 | $0.22 | $3,218,425,112 | 4 / 7 |
| 2026-09-14 | $0.22 | $3,218,425,112 | 4 / 7 |
| 2026-09-15 | $0.22 | $3,218,425,112 | 4 / 7 |
| 2026-09-16 | $0.22 | $3,218,425,112 | 4 / 7 |
| 2026-09-17 | $0.22 | $3,218,425,112 | 4 / 7 |
| 2026-09-18 | $0.22 | $3,218,425,112 | 4 / 7 |
| 2026-09-19 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-20 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-21 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-22 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-23 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-24 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-25 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-26 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-27 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-28 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-29 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-09-30 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-10-01 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-10-02 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-10-03 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-10-04 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-10-05 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-10-06 | $0.22 | $3,220,125,002 | 4 / 7 |
| 2026-10-07 | $0.22 | $3,207,091,669 | 4 / 7 |
| 2026-10-08 | $0.22 | $3,207,091,669 | 4 / 7 |
| 2026-10-09 | $0.22 | $3,207,091,669 | 4 / 7 |
| 2026-10-10 | $0.22 | $3,209,991,919 | 4 / 7 |
| 2026-10-11 | $0.22 | $3,209,991,919 | 4 / 7 |
| 2026-10-12 | $0.22 | $3,209,991,919 | 4 / 7 |
| 2026-10-13 | $0.22 | $3,209,991,919 | 4 / 7 |
| 2026-10-14 | $0.22 | $3,209,991,919 | 4 / 6 |
| 2026-10-15 | $0.22 | $3,209,991,919 | 4 / 6 |
| 2026-10-16 | $0.22 | $3,209,991,919 | 4 / 6 |
| 2026-10-17 | $0.22 | $3,209,991,919 | 4 / 6 |
| 2026-10-18 | $0.22 | $3,209,991,919 | 4 / 6 |
| 2026-10-19 | $0.22 | $3,209,991,919 | 4 / 6 |
| 2026-10-20 | $0.22 | $3,210,273,752 | 4 / 6 |
| 2026-10-21 | $0.22 | $3,210,273,752 | 4 / 6 |
| 2026-10-22 | $0.22 | $3,210,273,752 | 4 / 6 |
| 2026-10-23 | $0.22 | $3,210,273,752 | 4 / 6 |
| 2026-10-24 | $0.22 | $3,210,293,410 | 4 / 6 |
| 2026-10-25 | $0.22 | $3,210,293,410 | 4 / 6 |
| 2026-10-26 | $0.22 | $3,210,293,410 | 4 / 6 |
| 2026-10-27 | $0.22 | $3,210,293,410 | 4 / 6 |
| 2026-10-28 | $0.22 | $3,210,293,410 | 4 / 6 |
| 2026-10-29 | $0.22 | $3,125,864,878 | 4 / 6 |
| 2026-10-30 | $0.22 | $3,125,864,878 | 4 / 6 |
| 2026-10-31 | $0.22 | $3,125,864,878 | 4 / 6 |
| 2026-11-01 | $0.22 | $3,125,864,878 | 4 / 6 |
| 2026-11-02 | $0.22 | $3,125,864,878 | 4 / 6 |
| 2026-11-03 | $0.22 | $3,125,864,882 | 4 / 6 |
| 2026-11-04 | $0.20 | $3,143,420,438 | 4 / 6 |
| 2026-11-05 | $0.20 | $3,143,420,438 | 4 / 6 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 8 Buy / Strong Buy · 14 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 4 recorded
1 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.